Shah, N. C., Ngwube, A., Suresh, T., Sowa, A., Abraham, A., Anderson, E., Andreansky, M., Bhatia, M., Chaudhury, S., Cuvelier, G. D. E., Dalal, J., Grimley, M., Jacobsohn, D., Kamani, N., Krajewski, J., Krishnamurti, L., Saini, S., Skiles, J., & Shenoy, S. (2025). Impact of Abatacept Inclusive Graft Versus Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy. Transplantation and Cellular Therapy. https://doi.org/10.1016/j.jtct.2025.06.015

Anderson, G. A., Hernandez, M., Quinde, C. A., Thompson, Z., Binder-Blaser, V., Taylor, A. M., & Kathrein, K. L. (2025). Loss of ING4 enhances hematopoietic regeneration in multipotent progenitor cells. PLOS ONE, 20(2), e0316256. https://doi.org/10.1371/journal.pone.0316256

Shah, N. N., Schafer, E. S., Chi, Y., Malvar, J., Heym, K. M., Place, A. E., Burns, M., Chang, B. H., Slone, T., Verma, A., Gossai, N., Shaw, P. H., Burke, M. J., Hermiston, M., Schore, R. J., Cooper, T., Pauly, M., Rushing, T., Jarosinski, P., … Wayne, A. S. (2025). Vincristine Sulfate Liposome Injection with Combination Chemotherapy for Children, Adolescents, and Young Adults with Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial. Pediatric Blood & Cancer. Portico. https://doi.org/10.1002/pbc.31584

Gui, G., Ravindra, N., Hegde, P. S., Andrew, G., Mukherjee, D., Wong, Z., Auletta, J. J., El Chaer, F., Chen, E. C., Chen, Y.-B., Corner, A., Devine, S. M., Iyer, S. G., Jimenez Jimenez, A. M., De Lima, M. J. G., Litzow, M. R., Kebriaei, P., Saber, W., Spellman, S. R., … Hourigan, C. S. (2024). Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-024-02447-4

Baldassarri, I., Tavakol, D. N., Graney, P. L., Chramiec, A. G., Hibshoosh, H., & Vunjak-Novakovic, G. (2024). An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche. Proceedings of the National Academy of Sciences, 121(42). https://doi.org/10.1073/pnas.2405257121

DeFilipp, Z., Kim, H. T., Spyrou, N., Katsivelos, N., Kowalyk, S., Eng, G., Kasikis, S., Beheshti, R., Baez, J., Akahoshi, Y., Ayuk, F., Choe, H., Etra, A., Grupp, S. A., Hexner, E. O., Hogan, W. J., Kitko, C. L., Qayed, M., Reshef, R., … Chen, Y.-B. (2024). The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD. Blood Advances, 8(13), 3488–3496. https://doi.org/10.1182/bloodadvances.2024012561

Akahoshi, Y., Spyrou, N., Hoepting, M., Aguayo-Hiraldo, P., Ayuk, F., Chanswangphuwana, C., Choe, H. K., Eder, M., Etra, A. M., Grupp, S. A., Hexner, E. O., Hogan, W. J., Kitko, C. L., Kraus, S., Al Malki, M. M., Merli, P., Qayed, M., Reshef, R., Schechter, T., … Nakamura, R. (2024). Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis. Blood Advances, 8(8), 2047–2057. https://doi.org/10.1182/bloodadvances.2023012091

Gui, G., Dillon, L. W., Ravindra, N., Hegde, P. S., Andrew, G., Mukherjee, D., Wong, Z., Auletta, J. J., El Chaer, F., Chen, E. C., Chen, Y.-B., Corner, A., Devine, S. M., Iyer, S. G., Jimenez Jimenez, A. M., de Lima, M., Litzow, M. R., Kebriaei, P., Saber, W., … Hourigan, C. S. (2023). Measurable Residual IDH2 before Allogeneic Transplant for Acute Myeloid Leukemia. Blood, 142(Supplement 1), 424–424. https://doi.org/10.1182/blood-2023-186822

Akahoshi, Y., Spyrou, N., Weber, D., Aguayo-Hiraldo, P., Ayuk, F. A., Bunworasate, U., Choe, H., Eder, M., Etra, A., Grupp, S., Hexner, E. O., Hogan, W. J., Kitko, C. L., Kraus, S., Merli, P., Qayed, M., Reshef, R., Schechter-Finkelstein, T., Ullrich, E., … Nakamura, R. (2023). Flares of Acute Graft-Versus-Host Disease: Mount Sinai Acute Gvhd International Consortium (MAGIC) Study. Blood, 142(Supplement 1), 776–776. https://doi.org/10.1182/blood-2023-181900

Spyrou, N., Akahoshi, Y., Kowalyk, S., Morales, G., Beheshti, R., Aguayo-Hiraldo, P., Al Malki, M. M., Ayuk, F. A., Bader, P., Baez, J., Capellini, A., Choe, H., Defilipp, Z., Eder, M., Eng, G., Etra, A., Gleich, S., Grupp, S., Hexner, E., … Ferrara, J. L. M. (2023). A Day 14 Endpoint for Acute Gvhd Clinical Trials. Blood, 142(Supplement 1), 779–779. https://doi.org/10.1182/blood-2023-172955

Wang, X. K., Uzuni, A., Belay, K., Harle, D. W., Gordillo, C. A., Macedo, R. J., Chakrabarti, S., Shi, L., Pressler, M., Fuller, J., Azizi, E., & Reshef, R. (2023). Characteristics of Alloreactive T-Cell Clones That Predict Early Development of Acute GvHD Following Allogeneic HCT. Blood, 142(Supplement 1), 2042–2042. https://doi.org/10.1182/blood-2023-187932

Malki, M. A., Keyzner, A., Suh, H. C., Matin, A., Buonomo, E., Wang, Y., Abelowitz, N., Murray, J., MacBeath, G., Barton, D., Chattopadhyay, S., & Reshef, R. (2023). 682 Trial in progress: phase 1 trial of TSC-100 and TSC-101, engineered T-cell therapies targeting minor histocompatibility antigens to eliminate residual disease after hematopoietic cell transplantation. Regular and Young Investigator Award Abstracts. https://doi.org/10.1136/jitc-2023-sitc2023.0682

Mack, E., Dougher, M., Murter, M., Tanhehco, Y., Siegel, D., Fesnak, A., Bhoj, V., Kambayashi, T., Aqui, N., & O’Doherty, U. (2023). OA5‐AM23‐MN‐36 | Red Cell Exchange for Rapid Leukoreduction in Adults with Hyperleukocytosis and Leukostasis. Transfusion, 63(S5). Portico. https://doi.org/10.1111/trf.16_17554

Al Malki, M. M., London, K., Baez, J., Akahoshi, Y., Hogan, W. J., Etra, A., Choe, H., Hexner, E., Langston, A., Abhyankar, S., Ponce, D. M., DeFilipp, Z., Kitko, C. L., Adekola, K., Reshef, R., Ayuk, F., Capellini, A., Chanswangphuwana, C., Eder, M., … Levine, J. E. (2023). Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease. Blood Advances, 7(17), 5189–5198. https://doi.org/10.1182/bloodadvances.2023009853

Akahoshi, Y., Spyrou, N., Hogan, W. J., Ayuk, F., DeFilipp, Z., Weber, D., Choe, H. K., Hexner, E. O., Rösler, W., Etra, A. M., Sandhu, K., Yanik, G. A., Chanswangphuwana, C., Kitko, C. L., Reshef, R., Kraus, S., Wölfl, M., Eder, M., Bertrand, H., … Chen, Y.-B. (2023). Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD. Blood Advances, 7(16), 4479–4491. https://doi.org/10.1182/bloodadvances.2023009885

Ali, A. M., BenMohamed, F., Decina, A., Mukherjee, S., Levi, S., Garrido Castillo, L. N., Bréchot, D., Jurcic, J., Raza, A., & Paterlini Bréchot, P. (2023). Circulating cancer giant cells with unique characteristics frequently found in patients with myelodysplastic syndromes (MDS). Medical Oncology, 40(7). https://doi.org/10.1007/s12032-023-02064-z

Llore, N., Fujiki, M., Segovia, M., Jafri, S.-M., Obri, M., Liggett, J., Kroemer, A., Matsumoto, C., Moon, J., DiCocco, P., Selvaggi, G., Garcia, J., Ganoza, A., Khanna, A., Mazariegos, G., Wendel, D., Reyes, J., Ormsby, D., & Weiner, J. (2023). 28: The First Collective Examination of Immunosuppressive Practices Among American Intestine Transplant Centers. Transplantation, 107(7S), 15–15. https://doi.org/10.1097/01.tp.0000945568.31189.cb

Long, K. D., & Fu, J. (2023). Chimerism and phenotypic analysis of intraepithelial and lamina propria T cells isolated from human ileal biopsies after intestinal transplantation. STAR Protocols, 4(2), 102192. https://doi.org/10.1016/j.xpro.2023.102192

Putta, S., Young, B. A., Levine, J. E., Reshef, R., Nakamura, R., Strouse, C., Perales, M.-A., Howard, A., Pine, P., Shi, J., Zhang, P., Ho, V. T., & Saber, W. (2023). Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study. Transplantation and Cellular Therapy, 29(3), 166.e1-166.e10. https://doi.org/10.1016/j.jtct.2022.11.024

Etra, A., Capellini, A., Alousi, A., Al Malki, M. M., Choe, H., DeFilipp, Z., Hogan, W. J., Kitko, C. L., Ayuk, F., Baez, J., Gandhi, I., Kasikis, S., Gleich, S., Hexner, E., Hoepting, M., Kapoor, U., Kowalyk, S., Kwon, D., Langston, A., … Levine, J. E. (2023). Effective treatment of low-risk acute GVHD with itacitinib monotherapy. Blood, 141(5), 481–489. https://doi.org/10.1182/blood.2022017442

Kamle, A., Patrikar, S., Chaudhary, P., Malpani, P., & Satwani, P. (2023). Pediatric hematopoietic stem cell transplantation- Experience from a center in central India. Pediatric Hematology Oncology Journal, 8(4), S78. https://doi.org/10.1016/j.phoj.2023.10.198

Landau, H. J., Orlando, E., Rodriguez, E. S., Applebaum, A., Mitchell, H.-R., Peled, J. U., Khan, N., Funnell, T., Chung, D., Scordo, M., Shah, G. L., LeStrange, N. J., Hambright, K. A., McElrath, C. M., Cazeau, N., Devlin, S. M., Perales, M.-A., van den Brink, M. R. M., & Giralt, S. A. (2022). Pilot Trial of Homebound Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 28(12), 832.e1-832.e7. https://doi.org/10.1016/j.jtct.2022.09.014

Qiu, A., Wang, L., Dei Zotti, F., Hudson, K. E., Hod, E. A., & La Carpia, F. (2022). Iron Overload and Iron-Induced Microbiome Changes May Affect Lymphoid Levels Post Bone Marrow Transplant and Graft-Versus-Host Disease Survival in Mice. Blood, 140(Supplement 1), 2465–2466. https://doi.org/10.1182/blood-2022-167300

Platzbecker, U., Komrokji, R. S., Fenaux, P., Zeidan, A. M., Sekeres, M. A., Savona, M. R., Madanat, Y. F., Santini, V., Van Eygen, K., Raza, A., Germing, U., Berry, T., Dougherty, S., Shah, S., Sun, L., Huang, F., Feller, F., Wan, Y., Ikin, A., & Sherman, L. (2022). Imetelstat Achieved Prolonged, Continuous Transfusion Independence (TI) in Patients with Heavily Transfused Non-Del(5q) Lower-Risk Myelodysplastic Syndrome (LR-MDS) Relapsed/Refractory (R/R) to Erythropoiesis Stimulating Agents (ESAs) within the IMerge Phase 2 Study. Blood, 140(Supplement 1), 1106–1108. https://doi.org/10.1182/blood-2022-169050

Breyer, L. M., Wang, H., Gu, D., Johnstone, B. H., Ma, H., Woods, E. J., & Mapara, M. Y. (2022). Transplantation of Hematopoietic Stem and Progenitor Cells from Cadaveric Organ Donors Leads to Long-Term Multilineage Engraftment in NSG Mice. Blood, 140(Supplement 1), 7347–7348. https://doi.org/10.1182/blood-2022-169787

Chen, Y.-B., Saad, A., Farhan, S. Y., Lekakis, L. J., Schiller, G. J., Yared, J. A., Assal, A., Lee, D. D., Lane, H., Gooley, T. A., & Defilipp, Z. (2022). RGI-2001 Infusion for Prevention of Acute Gvhd after Allogeneic Hematopoietic Cell Transplantation. Blood, 140(Supplement 1), 1877–1878. https://doi.org/10.1182/blood-2022-162512

Capellini, A., Etra, A., Alousi, A. M., Al Malki, M. M., Choe, H., Defilipp, Z., Hogan, W. J., Kitko, C. L., Ayuk, F. A., Baez, J., Gandhi, I., Kasikis, S., Gleich, S., Hexner, E. O., Hoepting, M., Kapoor, U., Kowalyk, S., Kwon, D., Langston, A., … Levine, J. E. (2022). Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy. Blood, 140(Supplement 1), 1867–1869. https://doi.org/10.1182/blood-2022-156000

Koh, S. K., Park, J., Kim, S.-E., Lim, Y., Phan, M.-T. T., Kim, J., Hwang, I., Ahn, Y.-O., Shin, S., Doh, J., & Cho, D. (2022). Natural Killer Cell Expansion and Cytotoxicity Differ Depending on the Culture Medium Used. Annals of Laboratory Medicine, 42(6), 638–649. https://doi.org/10.3343/alm.2022.42.6.638

Otegbeye, F., Vina, M. A. F., Wang, T., Bolon, Y.-T., Lazaryan, A., Beitinjaneh, A., Bhatt, V. R., Castillo, P., Marsh, S. G. E., Hildebrandt, G. C., Assal, A., Brown, V. I., Hsu, J., Spellman, S., de Lima, M., & Lee, S. J. (2022). Natural Killer Cell Alloreactivity Predicted By Killer Cell Immunoglobulin-Like Receptor Ligand Mismatch Does Not Impact Engraftment in Umbilical Cord Blood and Haploidentical Stem Cell Transplantation. Transplantation and Cellular Therapy, 28(8), 483.e1-483.e7. https://doi.org/10.1016/j.jtct.2022.05.034

Nauman, G., Danzl, N. M., Lee, J., Borsotti, C., Madley, R., Fu, J., Hölzl, M. A., Dahmani, A., Dorronsoro Gonzalez, A., Chavez, É., Campbell, S. R., Yang, S., Satwani, P., Liu, K., & Sykes, M. (2022). Defects in Long-Term APC Repopulation Ability of Adult Human Bone Marrow Hematopoietic Stem Cells (HSCs) Compared with Fetal Liver HSCs. The Journal of Immunology, 208(7), 1652–1663. https://doi.org/10.4049/jimmunol.2100966

Bansal, R., Park, H., Taborda, C. C., Gordillo, C., Mapara, M. Y., Assal, A., Uhlemann, A.-C., & Reshef, R. (2022). Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 28(3), 135–144. https://doi.org/10.1016/j.jtct.2021.12.015

Menghrajani, K., Gomez-Arteaga, A., Madero-Marroquin, R., Zhang, M.-J., Bo-Subait, K., Sanchez, J., Wang, H.-L., Aljurf, M., Assal, A., Bacher, V. U., Badawy, S. M., Bejanyan, N., Bhatt, V. R., Bredeson, C., Byrne, M., Castillo, P., Cerny, J., Chhabra, S., Ciurea, S. O., … Saber, W. (2022). Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Advances, 6(3), 828–847. https://doi.org/10.1182/bloodadvances.2021004881

Zou, J., Wang, T., He, M., Bolon, Y.-T., Gadalla, S. M., Marsh, S. G. E., Kuxhausen, M., Gale, R. P., Sharma, A., Assal, A., Prestidge, T., Aljurf, M., Cerny, J., Paczesny, S., Spellman, S. R., Lee, S. J., & Ciurea, S. O. (2022). Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study. Transplantation and Cellular Therapy, 28(2), 107.e1-107.e8. https://doi.org/10.1016/j.jtct.2021.11.001

Kadia, T. M., Pemmaraju, N., Yilmaz, M., Daver, N., Li, L., Lyu, M.-A., Huang, M., Zeng, K., Cook, R., Parmar, S., Mukherjee, S., Sadeghi, T., DiNardo, C. D., Issa, G. C., Jabbour, E. J., Borthakur, G., Jain, N., & Verstovsek, S. (2021). Adoptive Therapy with Allogeneic Cord Blood T Regulatory Cells Improves Transfusion Requirement in Bone Marrow Failure Syndromes. Blood, 138(Supplement 1), 3875–3875. https://doi.org/10.1182/blood-2021-153864

Kahn, J. M., Bo-Subait, S., Buchbinder, D. K., Hamilton, B. K., Schoemans, H., Brazauskas, R., Phelan, R., & Satwani, P. (2021). Late Effects after Allogeneic Hematopoietic Cell Transplantation Among Children and Adolescents with Non-Malignant Disorders: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR). Blood, 138(Supplement 1), 412–412. https://doi.org/10.1182/blood-2021-151446

Metheny, L., Callander, N. S., Hall, A. C., Zhang, M.-J., Bo-Subait, K., Wang, H.-L., Agrawal, V., Al-Homsi, A. S., Assal, A., Bacher, U., Beitinjaneh, A., Bejanyan, N., Bhatt, V. R., Bredeson, C., Byrne, M., Cairo, M., Cerny, J., DeFilipp, Z., Perez, M. A. D., … de Lima, M. (2021). Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults. Transplantation and Cellular Therapy, 27(11), 923.e1-923.e12. https://doi.org/10.1016/j.jtct.2021.08.010

Gao, L., Decker, M., Chen, H., & Ding, L. (2021). Thrombopoietin from hepatocytes promotes hematopoietic stem cell regeneration after myeloablation. ELife, 10. CLOCKSS. https://doi.org/10.7554/elife.69894